News|Articles|August 1, 2025
How One Brand Protected Market Share Amid Biosimilar Pressure
Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote
2
BMS vs. Moderna vs. Pfizer: The RNA Platform Race
3
Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO
4
U.S. Prescription Drug Spending Set to Exceed $1 Trillion in 2026: Report
5